Dec 27, 2004
HEMISPHERX BIOPHARMA FILES LAWSUIT IN FEDERAL COURT ALLEGING CONSPIRACY BY FOREIGN NATIONALS TO MANIPULATE ITS STOCK PRICE AND ENGAGE IN ILLEGAL HOSTILE TAKEOVER

Dec 21, 2004
Los Angeles Times Article Focuses on Hemispherx Biopharma's Experimental Drug Ampligen as a Potential New Therapy for Chronic Fatigue Syndrome

Nov 22, 2004
HEMISPHERX BIOPHARMA INITIATES ALFERON LDO® CLINICAL PROGRAM IN COLLABORATION WITH PRINCESS MARGARET HOSPITAL IN HONG KONG

Nov 12, 2004
HEMISPHERX BIOPHARMA THIRD QUARTER 2004 EARNINGS ANNOUNCED

Nov 08, 2004
HEMISPHERX BIOPHARMA TO PRESENT AT THE NEW YORK SOCIETY OF SECURITY ANALYSTS 8TH ANNUAL HEALTHCARE INDUSTRY CONFERENCE

Nov 01, 2004
Hemispherx Biopharma Presented New Data at the 44th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy in Washington, D.C.

Oct 25, 2004
HEMISPHERX BIOPHARMA TO PRESENT AT THE RODMAN & RENSHAW TECHVEST 6TH ANNUAL HEALTHCARE CONFERENCE ON OCTOBER 27th

Oct 20, 2004
Unexpected Neurological Damage Spreads with West Nile Virus; Heightens Concern in Healthcare Community

Oct 18, 2004
Hemispherx Biopharma Comments on Recent Release of Data on Primary Endpoint in Phase III Chronic Fatigue Syndrome Study

Oct 11, 2004
HEMISPHERX BIOPHARMA PRESENTS NEWPHASE III DATA ON AMPLIGEN® AT THE 7th INTERNATIONAL CONFERENCE FOR CHRONIC FATIGUE SYNDROME

 55   56   57   58   59     60    61   62   63   64   65